Nebulized Heparin for the Treatment of COVID-19 Induced Lung Injury
NCT04397510 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 13
Last updated 2024-04-03
Summary
Randomized, placebo controlled study to determine if nebulized heparin may reduce the severity of lung injury caused by the novel coronavirus, also known as COVID-19
Conditions
- Covid-19
- ARDS, Human
- Acute Lung Injury
Interventions
- DRUG
-
Heparin
Nebulized Heparin
- DRUG
-
0.9% Sodium-chloride
Nebulized 0.9% Sodium Chloride
Sponsors & Collaborators
-
Frederick Health
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-06-01
- Primary Completion
- 2021-12-31
- Completion
- 2021-12-31
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Hypertonic Modulation of Inflammation Following Injury
NCT00750997 ·Status: TERMINATED
-
Impact of Tissue Plasminogen Activator (tPA) Treatment for an Atypical Acute Respiratory Distress Syndrome (COVID-19)
NCT04453371 ·Status: WITHDRAWN ·Phase: PHASE3
-
When Heparin Stopped for Anticoagulation During ECMO Decannulation
NCT05239637 ·Status: UNKNOWN ·Phase: NA
-
Calfactant for Direct Acute Respiratory Distress Syndrome
NCT00682500 ·Status: TERMINATED ·Phase: PHASE3
-
Nebulized Furosemide, Heparin, Hypertonic Saline in Mechanically Ventilated Acute Respiratory Distress Syndrome Adult Patients
NCT07286409 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Plasma Exchange in Patients With COVID-19 Disease and Invasive Mechanical Ventilation: a Randomized Controlled Trial
NCT04374539 ·Status: TERMINATED ·Phase: PHASE2
-
Transfusion of Fresh Frozen Plasma in Non-bleeding Intensive Care Unit (ICU) Patients
NCT01143909 ·Status: COMPLETED ·Phase: NA
-
Field Trial of Hypotensive Versus Standard Resuscitation for Hemorrhagic Shock After Trauma
NCT01411852 ·Status: COMPLETED ·Phase: PHASE2
-
Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS
NCT04333368 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Hypertonic Saline Resuscitation in Trauma Patients After Hemorrhage Control
NCT02542241 ·Status: TERMINATED ·Phase: PHASE4
-
Treatment of Severe and Critical COVID-19 Pneumonia With Convalescent Plasma
NCT04432103 ·Status: TERMINATED ·Phase: PHASE3
-
Extracellular Vesicle Infusion Treatment for COVID-19 Associated ARDS
NCT04493242 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Nebulized and Intravenous Hypertonic Saline 3% on the Management of Patients With Acute Respiratory Distress Syndrome
NCT06226402 ·Status: RECRUITING ·Phase: NA
-
Impact of Intravenous Lidocaine on Clinical Outcomes of Patients With ARDS During COVID-19 Pandemia
NCT04609865 ·Status: TERMINATED ·Phase: PHASE3
-
Nebulized hypErtonic Saline for Better Prevention of mUcus pLug in Critical Adult Tracheostomized Patients
NCT03870646 ·Status: UNKNOWN ·Phase: PHASE3
-
Randomized Trial of Fresh Frozen Plasma Versus Albumin in Acute Burn Resuscitation
NCT05069922 ·Status: COMPLETED ·Phase: NA
-
Safety and Effectiveness of Placental Derived Exosomes and Umbilical Cord Mesenchymal Stem Cells in Moderate to Severe Acute Respiratory Distress Syndrome (ARDS) Associated With the Novel Corona Virus Infection (COVID-19)
NCT05387278 ·Status: SUSPENDED ·Phase: PHASE1
-
Infusion Rate and Volume Kinetics for Hyperoncotic Albumine in Healthy Subjects
NCT03453320 ·Status: COMPLETED ·Phase: PHASE4
-
Physiological Effects of 38°C vs. 22°C Fluid Therapy in Critically Ill Patients
NCT04576806 ·Status: WITHDRAWN ·Phase: NA
-
A Pilot Study of Human Amniotic Fluid for COVID19 Associated Respiratory Failure
NCT04319731 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Glucocorticoid Therapy for Acute Respiratory Distress Syndrome
NCT05401812 ·Status: WITHDRAWN ·Phase: PHASE2
-
Controlled Fluid Removal in Critical Ill Patients With Fluid Overload in the Intensive Care Unit.
NCT04180397 ·Status: RECRUITING ·Phase: PHASE4
-
London's Exogenous Surfactant Study for COVID19
NCT04375735 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Hemodynamics and Extravascular Lung Water in Acute Lung Injury
NCT00624650 ·Status: COMPLETED ·Phase: PHASE2
-
COVID-19 Resuscitation Plans and Decisions on Escalation and Limitation of Treatment
NCT04743232 ·Status: SUSPENDED ·Phase: NA